MedPath

ALCON RESEARCH

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

DisCoVisc Versus DuoVisc, Healon5 and AmVisc Plus

Phase 4
Completed
Conditions
Cataract
Interventions
Device: DisCoVisc
Device: DuoVisc
Device: Healon5
Device: Amvisc Plus
First Posted Date
2008-07-09
Last Posted Date
2010-09-14
Lead Sponsor
Alcon Research
Target Recruit Count
112
Registration Number
NCT00712244
Locations
🇺🇸

Contact Alcon Call Center for Study Locations, Fort Worth, Texas, United States

Visual Function With Bilateral AcrySof® ReSTOR® Aspheric SN6AD1

Phase 4
Completed
Conditions
Cataract
Interventions
Device: AcrySof ReSTOR Aspheric IOL model SN6AD1
First Posted Date
2008-07-08
Last Posted Date
2011-12-12
Lead Sponsor
Alcon Research
Target Recruit Count
35
Registration Number
NCT00710931
Locations
🇺🇸

Contact Alcon Call Center for Trial Locations, Fort Worth, Texas, United States

Blue Light Intraocular Lenses (IOLs) and Photostress

Completed
Conditions
Cataract
First Posted Date
2008-07-08
Last Posted Date
2010-02-02
Lead Sponsor
Alcon Research
Target Recruit Count
58
Registration Number
NCT00710996
Locations
🇺🇸

Call Alcon Call Center for Study Locations, Fort Worth, Texas, United States

Intraoperative Floppy Iris Syndrome

Phase 4
Completed
Conditions
Cataract
Floppy Iris Syndrome
Interventions
Device: DisCoVisc
Device: Healon5
First Posted Date
2008-07-08
Last Posted Date
2010-08-10
Lead Sponsor
Alcon Research
Target Recruit Count
28
Registration Number
NCT00711347
Locations
🇺🇸

Contact Alcon Call Center for Study Locations, Fort Worth, Texas, United States

Visual Function With Contralateral AcrySof® ReSTOR® Aspheric SN6AD1 and SN6AD3

Phase 4
Terminated
Conditions
Cataract
Interventions
Device: AcrySof ReSTOR Aspheric IOL models SN6AD1 and SN6AD3
First Posted Date
2008-07-08
Last Posted Date
2011-11-24
Lead Sponsor
Alcon Research
Target Recruit Count
50
Registration Number
NCT00710905
Locations
🇨🇦

Dr Dominique Meyer, Quebec City, Quebec, Canada

🇨🇦

Dr John Blaylock, Abbotsford, British Columbia, Canada

Effects of Travatan Z and Xalatan on Ocular Surface Health

First Posted Date
2008-07-02
Last Posted Date
2012-04-23
Lead Sponsor
Alcon Research
Target Recruit Count
231
Registration Number
NCT00708422

A Multi-Dose Study With a Treatment for Open-Angle Glaucoma

Phase 2
Withdrawn
Conditions
Open-Angle Glaucoma
Interventions
First Posted Date
2008-06-26
Last Posted Date
2012-05-30
Lead Sponsor
Alcon Research
Registration Number
NCT00705770

Evaluation of SYSTANE Ultra Lubricant Eye Drops

Not Applicable
Completed
Conditions
Dry Eye
Interventions
Other: SYSTANE Ultra
Other: Optive
First Posted Date
2008-06-20
Last Posted Date
2012-02-02
Lead Sponsor
Alcon Research
Target Recruit Count
109
Registration Number
NCT00702377
Locations
🇺🇸

Contact Call Center for Locations, Fort Worth, Texas, United States

Tobramycin Tear Concentrations

First Posted Date
2008-06-11
Last Posted Date
2010-03-02
Lead Sponsor
Alcon Research
Target Recruit Count
21
Registration Number
NCT00695435
Locations
🇺🇸

Contact Alcon Call Center For Trial Locations, Fort Worth, Texas, United States

Travatan Z in Ocular Surface Health in Patients With Open-Angle Glaucoma or Ocular Hypertension

First Posted Date
2008-06-05
Last Posted Date
2012-07-24
Lead Sponsor
Alcon Research
Target Recruit Count
726
Registration Number
NCT00690794
© Copyright 2025. All Rights Reserved by MedPath